Report of the Directors The Directors present their report and the audited group accounts of Amersham plc for the year ended 31 December 2003.
Principal activities and business review The group is engaged in the worldwide development, manufacture and sale of specialised products for research-based biotechnology supply and for the diagnosis and treatment of disease.
The Chairmans and Chief Executives review on pages 4 to 6 and Financial review on pages 7 to 9 contain further information on the business activities of the group.
Results Sales of continuing operations were 1,652 million, including a 82 million share of joint ventures sales.
Exports from the United Kingdom amounted to 237 million.
The group profit and loss account appears on page 30.
Profit for the year attributable to shareholders amounted to 116 million.
The Directors recommend that this be dealt with as follows: m Ordinary dividends - Interim dividend paid 2.85p per share 20 - Proposed dividend 5.92p per share 42 62 Transfer to reserves 54 Profit attributable to shareholders 116 A dividend of 5.92p per share is recommended.
Research and development Group policy is to invest in product innovation and process improvement at a level designed to enable it to be a market leader in the diagnostic imaging and biotechnology supply businesses in which it competes.
It is also group policy to seek out new business opportunities by exploiting its skills and technological base.
Directors Directors who have served during the year are detailed below: Remuneration Audit Nomination Committee Committee Committee Mr G W Battersby Mr D H Brydon CBE Appointed Chairman on 7 May 2003 Dr A Carr Sir William Castell Mr D Challen CBE Appointed on 5 August 2003 Mr J H Johansen Mr G F B Kerr Mr R D Lapthorne CBE Retired on 7 May 2003 Mr P Loescher Mr J Fr Odfjell Dr J S Patterson Professor Sir Keith Peters Mr J F Rejeange Professor E Thorsby Professor M Uhlen 11 Appointments to the Board are recommended by the Nomination Committee, details of which are given in the Corporate Governance statement on page 14.
Directors interests in shares of the company The beneficial interests of the Directors in the shares of the company at 1 January 2003 and 31 December 2003 are shown in the Directors remuneration report together with details of changes in the Directors share interests between 31 December 2003 and 13 February 2004.
No Director holds any non-beneficial interests in shares of the company.
Interest in companys shares During the year, the company funded the purchase of its own ordinary shares, nominal value 5p, through the Amersham Qualifying Employee Share Ownership Trust for the benefit of employees under the groups share save scheme.
Number Percentage of issued Aggregate of shares share capital consideration Trust % Amersham Qualifying Employee Share 49,525 0.007 244,158 Ownership Trust Shares purchased under Amersham Qualifying Employee Share Ownership Trust have been used to satisfy the exercise of options granted under the share save SAYE scheme, which is more fully explained on page 21 of the Remuneration report.
Employee share schemes Amersham plc operates share option schemes for senior executives throughout the group and all employees in the UK, US and Norway.
Details of the shares issued and options granted under these schemes are shown in note 25 to the financial statements.
The company also has long term incentive plans.
Details of grants to Executive Directors are given in the Directors remuneration report on pages 27 to 28.
Employment of disabled persons The policy of the group is to recruit, train and provide career development opportunities to disabled persons on the same basis as other staff and to make every effort to retain and assist any individuals disabled in the course of their employment.
Employee involvement There are extensive arrangements in the UK and in overseas subsidiary undertakings for consultation with staff on group objectives, plans and progress and on matters of general or particular interest.
Regular exchanges of information with staff take place through formal consultative arrangements at corporate and local level.
The employee share schemes approved by the shareholders have been successful in encouraging employee share ownership.
Political and charitable contributions Financial contributions to charities and good causes during the reporting period in the UK amounted to 279,238.
Additional contributions were made through staff time, equipment and gifts in kind.
The Social and Environment report on page 10 provides information on donations to other good causes.
No political donations were made.
12 Supplier payment policy The group applies a policy of agreeing and clearly communicating the terms of payment as part of the commercial arrangements negotiated with suppliers and then paying according to those terms.
In addition the UK-based businesses follow the guidance in the DTI publication to the Better Payment Practice.
A copy of the guide can be obtained from the Department of Trade and Industry, DTI Publications, Orderline, Admail 528, London SW1W 8YT.
For UK businesses at 31 December 2003, trade creditors represented 28 days 2002 - 26 days, equivalent of aggregate amounts invoiced by suppliers during the year.
Substantial shareholdings The company has been notified under the provisions of the Companies Act 1985 as amended that on 13 February 2004 the following had a material interest in 3% or more of the companys ordinary share capital: Number of shares % Deutsche Bank AG London 64,102,882 9.0877 UBS Investment Bank 57,065,906 8.0901 Credit Suisse First Boston Equities Limited 43,151,544 6.1175 Lehman Brothers International Europe 35,726,877 5.0649 Merrill Lynch Investment Managers Limited 34,196,620 4.8480 Cater Allen International Limited 29,531,159 4.1866 Lazard Asset Management 21,658,981 3.0706 Folketrygdfondet 21,620,300 3.0651 Legal & General 21,561,744 3.0568 Annual General Meeting The Annual General Meeting will be held on 5 May 2004.
Further details are set out in the separate Chairman's Letter and Notice of Annual General Meeting.
Post balance sheet events On 21 January 2004, the group announced that the pre-conditions to the making of the share exchange acquisition of Amersham plc by General Electric Company and GE Investments Inc had been satisfied.
The pre-conditions included regulatory clearance from the European Commission and from the US anti-trust authorities.
Completion of the acquisition remains subject to a number of customary conditions, including the approval of Amersham shareholders and the sanction of the Scheme by the High Court and is expected in April.
On 2 February 2004, the group completed the exit from its investment in Cimarron Software Inc, by selling the groups holding for US $1, although the group will continue to distribute Cimarron products.
Auditors A resolution to reappoint  LLP as auditors to the company will be proposed at the Annual General Meeting.
By order of the board Mr R E B Allnutt Company Secretary 19 February 2004 13
